局所疼痛緩和の世界市場

局所疼痛緩和の世界市場は2030年までに109億米ドルに達する見込み

2024年に84億米ドルと推定される局所疼痛緩和の世界市場は、2024年から2030年にかけてCAGR 4.5%で成長し、2030年には109億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるオピオイド／麻薬は、CAGR 3.8％を記録し、分析期間終了時には74億米ドルに達すると予測されます。非オピオイド分野の成長率は、分析期間中CAGR 6.1％と推定されます。

米国市場は23億米ドルと推定、中国はCAGR 7.0％で成長予測

米国の局所疼痛緩和市場は2024年に23億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに21億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは7.0%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ2.2%と4.5%と予測されています。欧州では、ドイツがCAGR 2.8%で成長すると予測されています。

世界の「局所疼痛緩和」市場- 主要動向と促進要因のまとめ

局所疼痛緩和が経口鎮痛薬の代替品として急増している理由とは？

局所疼痛緩和の世界市場は力強い成長を遂げているが、その主な理由は、消費者やヘルスケアプロバイダーの間で、局所的で非侵襲的、副作用のない疼痛管理へのシフトが進んでいるためです。クリーム、ジェル、スプレー、パッチを含む局所鎮痛剤は、患部に直接塗布することで、経口鎮痛剤によくある全身吸収のリスクを伴わず、より迅速な緩和を可能にします。この魅力は、変形性関節症、腰痛、神経障害などの慢性的な筋骨格系疾患に苦しむ患者や、スポーツ外傷からの回復期にある患者に特に強いです。世界の人口が高齢化し、関節痛や筋肉痛の有病率が上昇するにつれ、特に欧州や日本など高齢者人口が急速に拡大している地域では、安全で効果的な疼痛管理に対する需要が急増しています。オピオイド処方に対する規制上の制限や社会的監視の高まりは、局所代替薬への切り替えをさらに加速させています。ヘルスケア専門家は、局所的な痛みの第一選択薬として、非ステロイド性抗炎症薬やカプサイシンベースの外用剤を推奨するようになっています。市販されているため利便性が高く、薬物相互作用の可能性が低いことから、これらの製品はセルフケアと医師が推奨するシナリオの両方において特に魅力的です。

製品イノベーションとデリバリー技術は市場をどのように変革しているか？

イノベーションは局所疼痛緩和市場の進化における重要な促進要因であり、製剤メーカーは有効性、浸透性、使用感を向上させるために先進的なドラッグデリバリーシステムを活用しています。最近の製品は、ジクロフェナク、リドカイン、メントールのような活性化合物の皮膚バリア透過性を高めるリポソームデリバリー、ナノキャリア技術、経皮パッチをますます取り入れるようになっています。これらの技術は、より深い組織への浸透を可能にするだけでなく、徐放性を確保し、頻繁な再貼付を必要とせずに緩和期間を延長します。さらに、メーカー各社は従来の製剤にとどまらず、慢性関節痛からスポーツ関連のケガまで、さまざまな使用事例に合わせたロールオン、スプレー、ハイドロゲル・パッチなどにも手を広げています。CBD（カンナビジオール）、ウコン抽出物、エッセンシャルオイルなどの補完成分の添加は、特にウェルネス志向やホリスティック志向の消費者の間で支持を集めています。ブランドはまた、小児や皮膚科的に敏感なユーザーなど、よりニッチだが成長中のセグメントを取り込むため、使いやすいパッケージ、無香料バージョン、低刺激性処方に注力しています。こうした進歩はすべて、混雑した市場での製品の差別化に役立つと同時に、複数の消費者層への応用範囲を広げています。

ウェルネス消費者の裾野拡大は市場の境界を再定義するか？

ウェルネス・ムーブメントの高まりは、従来の疼痛患者だけでなく、局所疼痛緩和製品の利用者を大幅に拡大しています。消費者は現在、運動後の痛みからデジタル機器に関連した首や肩の痛みまで、日常的な不調の回復ソリューションを積極的に求めており、医薬品とウェルネス製品の境界線を曖昧にしています。特にミレニアル世代とZ世代は、天然素材や植物由来の鎮痛剤に対する需要を牽引しており、外用鎮痛剤は反応性の薬ではなく、総合的なセルフケアレジメンの一部とみなしています。このシフトは、ウェルネスと鎮痛剤のハイブリッド製品の普及に拍車をかけ、多くの場合ライフスタイル・プラットフォームを通じて販売され、eコマース・マーケットプレース、ジム、スパ、健康食品小売店など、薬局以外のチャネルを通じて販売されています。フィットネス・インフルエンサーやウェルネス擁護者がソーシャルメディア上でこれらの製品を支持する人気も、日常的な使用を常態化させています。さらに、遠隔医療やオンライン薬局の普及が、製品の認知度向上や教育に貢献し、試用やリピート購入を促しています。特にアジア太平洋とラテンアメリカでは、地域のハーブや伝統的な鎮痛オイルが現代的な外用剤に組み込まれ、伝統的なものと健康志向の両方の感情にアピールしているため、地域的・文化的なシフトが需要をさらに促進しています。

局所疼痛緩和市場の需要増加の背景にあるマーケットカタリストは何か？

局所疼痛緩和市場の成長は、製剤の革新、エンドユーザーの動向、ヘルスケアダイナミクスの変化など、いくつかの要因によって牽引されています。技術的には、スキンデリバリーシステムの改良と経皮パッチの革新が治療効果を高めると同時に、投与回数と刺激を減らし、患者の満足度とアドヒアランスを高めることにつながっています。最終用途の拡大という点では、スポーツ障害、加齢に伴う関節疾患、座りっぱなしのライフスタイルに起因する筋肉の不快感の増加が、あらゆる年齢層で持続的な需要を生み出しています。消費者の行動も進化しており、非侵襲的で即効性のある自然な疼痛管理法を好む傾向が顕著になっているため、OTCやウェルネス一体型の外用製品の利用が増加しています。オピオイドの使用制限やNSAIDベースの第一選択治療に対する医師の嗜好など、規制面での追い風も市場成長を後押ししています。また、予防医療やフィットネス習慣の回復に注目が集まっていることに加え、デジタル・プラットフォームやインフルエンサーの支持を通じた知名度の高さも、製品の使用を正常化・拡大する一助となっています。最後に、薬局チェーン、eコマース、ウェルネスセンター、代替医療店舗での流通が拡大し、世界のアクセシビリティが向上しているため、局所疼痛緩和製品はより幅広い疼痛管理領域で好まれる選択肢となっています。

セグメント

クラス（オピオイド／麻薬、非オピオイド）;剤形（スプレー、パッチ、クリーム、フォーム）;流通チャネル（病院薬局、小売薬局、ドラッグストア、オンラインプラットフォーム、その他の流通チャネル）

調査対象企業の例（全41件）

• AdvaCare Pharma
• Amneal Pharmaceuticals LLC
• Bayer AG
• Chattem, Inc.（Sanofi subsidiary）
• Cipla Limited
• Dr. Reddy's Laboratories Ltd.
• GlaxoSmithKline plc（GSK）
• Glenmark Pharmaceuticals Ltd.
• Haleon plc
• Hisamitsu Pharmaceutical Co., Inc.
• Johnson & Johnson
• Mallinckrodt Pharmaceuticals
• Medherant Ltd
• Nestle S.A.
• Novartis AG
• Pfizer Inc.
• Procter & Gamble Co.
• Reckitt Benckiser Group plc
• Sanofi S.A.
• Teva Pharmaceutical Industries Ltd.

関税影響係数

Global Industry Analystsは、本社国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、人為的な売上原価の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

Global Industry Analystsは、世界の主要なチーフ・エコノミスト（1万4,949人）、シンクタンク（62団体）、貿易・産業団体（171団体）の専門家の意見に熱心に従いながら、エコシステムへの影響を評価し、新たな市場の現実に対処しています。あらゆる主要国の専門家やエコノミストが、関税とそれが自国に与える影響についての意見を追跡調査しています。

Global Industry Analystsは、この混乱が今後2-3ヶ月で収束し、新しい世界秩序がより明確に確立されると予想しています。Global Industry Analystsは、これらの開発をリアルタイムで追跡しています。

2025年4月：交渉フェーズ

4月のリリースでは、世界市場全体に対する関税の影響を取り上げ、地域別の市場調整について紹介します。当社の予測は、過去のデータと進化する市場影響要因に基づいています。

2025年7月：最終関税リセット

お客様には、各国間で最終リセットが発表された後、7月に無料アップデート版をお届けします。最終アップデート版には、明確に定義された関税影響分析が組み込まれています。

相互および二国間貿易と関税の影響分析：

アメリカ <>中国<>メキシコ <>カナダ <>EU <>日本<>インド <>その他176カ国

業界をリードするエコノミスト：Global Industry Analystsの知識ベースは、国家、シンクタンク、貿易・産業団体、大企業、そして世界の計量経済状況におけるこの前例のないパラダイムシフトの影響を共有する領域の専門家など、最も影響力のあるチーフエコノミストの厳選されたグループを含む1万4,949人のエコノミストを追跡しています。我々の16,491以上のレポートのほとんどは、マイルストーンに基づくこの2段階のリリーススケジュールを取り入れています。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Topical Pain Relief Market to Reach US$10.9 Billion by 2030

The global market for Topical Pain Relief estimated at US$8.4 Billion in the year 2024, is expected to reach US$10.9 Billion by 2030, growing at a CAGR of 4.5% over the analysis period 2024-2030. Opioids / Narcotics, one of the segments analyzed in the report, is expected to record a 3.8% CAGR and reach US$7.4 Billion by the end of the analysis period. Growth in the Non-Opioids segment is estimated at 6.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.3 Billion While China is Forecast to Grow at 7.0% CAGR

The Topical Pain Relief market in the U.S. is estimated at US$2.3 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$2.1 Billion by the year 2030 trailing a CAGR of 7.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.2% and 4.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.8% CAGR.

Global "Topical Pain Relief" Market - Key Trends & Drivers Summarized

Why Is Topical Pain Relief Surging as a Preferred Alternative to Oral Analgesics?

The global topical pain relief market is experiencing robust growth, largely due to an increasing shift among consumers and healthcare providers toward localized, non-invasive, and side-effect-free pain management. Topical analgesics, including creams, gels, sprays, and patches, provide direct application to the affected area, enabling faster relief without systemic absorption risks common to oral painkillers. This appeal is particularly strong among patients suffering from chronic musculoskeletal conditions like osteoarthritis, back pain, and neuropathy, as well as those recovering from sports injuries. As the global population ages and the prevalence of joint and muscle pain rises, especially in regions with rapidly expanding elderly populations such as Europe and Japan, the demand for safe and effective pain management is surging. Regulatory restrictions and growing public scrutiny over opioid prescriptions are further accelerating the switch to topical alternatives. Healthcare professionals are increasingly recommending topical NSAIDs and capsaicin-based products for first-line treatment of localized pain. The convenience of over-the-counter availability and minimal drug interaction potential make these products especially attractive in both self-care and physician-recommended scenarios.

How Are Product Innovations and Delivery Technologies Transforming the Market?

Innovation is a key driver in the evolution of the topical pain relief market, with formulators leveraging advanced drug delivery systems to improve efficacy, penetration, and user experience. Modern products are increasingly incorporating liposomal delivery, nanocarrier technologies, and transdermal patches that enhance the permeability of active compounds like diclofenac, lidocaine, and menthol through the skin barrier. These technologies not only enable deeper tissue penetration but also ensure sustained release, extending relief duration without the need for frequent reapplication. Moreover, manufacturers are expanding beyond traditional formulations to include roll-ons, sprays, and hydrogel patches tailored for various use-cases-from chronic arthritic pain to sports-related injuries. The addition of complementary ingredients such as CBD (cannabidiol), turmeric extracts, and essential oils is gaining traction, especially among wellness-driven and holistic consumers. Brands are also focusing on user-friendly packaging, fragrance-free versions, and hypoallergenic formulas to capture more niche but growing segments like pediatric and dermatologically sensitive users. All these advancements are helping differentiate products in a crowded market while also broadening the scope of applications across multiple consumer demographics.

Is the Expanding Base of Wellness Consumers Redefining Market Boundaries?

Yes, the growing wellness movement has significantly expanded the audience for topical pain relief products beyond traditional pain patients. Consumers now proactively seek recovery solutions for everyday discomforts-from post-workout soreness to digital device-related neck and shoulder pain-blurring the line between medicinal and wellness products. Millennials and Gen Z, in particular, are driving demand for natural and plant-based pain relief options, viewing topical analgesics as part of an overall self-care regimen rather than reactive medication. This shift has spurred the proliferation of hybrid wellness-pain relief products, often marketed through lifestyle platforms and sold through non-pharmacy channels like e-commerce marketplaces, gyms, spas, and health food retailers. The popularity of fitness influencers and wellness advocates endorsing these products on social media has also normalized their everyday use. Additionally, the increased adoption of telehealth and online pharmacies is contributing to product visibility and education, encouraging trial and repeat purchases. Regional and cultural shifts, particularly in Asia-Pacific and Latin America, are further fueling demand as local herbs and traditional pain-relieving oils are being integrated into modern topical formulations, appealing to both heritage and health-conscious sentiments.

What Are the Catalysts Behind the Rising Demand in the Topical Pain Relief Market?

The growth in the topical pain relief market is driven by several factors spanning formulation innovation, end-user trends, and shifting healthcare dynamics. Technologically, improved skin delivery systems and transdermal patch innovations are enhancing treatment efficacy, while reducing dosing frequency and irritation-leading to higher patient satisfaction and adherence. In terms of end-use expansion, rising incidences of sports injuries, age-related joint conditions, and sedentary lifestyle-induced muscular discomfort are creating sustained demand across all age groups. Consumer behavior has also evolved, with a clear preference for non-invasive, fast-acting, and natural pain management methods, leading to increased uptake of OTC and wellness-integrated topical products. Regulatory tailwinds such as restrictions on opioid use and physician preference for NSAID-based first-line treatments are favoring market growth. The increased focus on preventive care and recovery in fitness routines, coupled with high visibility through digital platforms and influencer endorsements, is also helping normalize and amplify product use. Lastly, growing distribution across pharmacy chains, e-commerce, wellness centers, and alternative medicine outlets is enhancing global accessibility, making topical pain relief products a preferred choice in the broader pain management spectrum.

SCOPE OF STUDY:

The report analyzes the Topical Pain Relief market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Class (Opioids / Narcotics, Non-Opioids); Form (Sprays, Patches, Creams, Foams); Distributional Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Platforms, Other Distribution Channels)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

• AdvaCare Pharma
• Amneal Pharmaceuticals LLC
• Bayer AG
• Chattem, Inc. (Sanofi subsidiary)
• Cipla Limited
• Dr. Reddy's Laboratories Ltd.
• GlaxoSmithKline plc (GSK)
• Glenmark Pharmaceuticals Ltd.
• Haleon plc
• Hisamitsu Pharmaceutical Co., Inc.
• Johnson & Johnson
• Mallinckrodt Pharmaceuticals
• Medherant Ltd
• Nestle S.A.
• Novartis AG
• Pfizer Inc.
• Procter & Gamble Co.
• Reckitt Benckiser Group plc
• Sanofi S.A.
• Teva Pharmaceutical Industries Ltd.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Topical Pain Relief - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Aging Population and Rise in Musculoskeletal Disorders Propel Growth
  • Preference for Non-Invasive, Non-Opioid Pain Management Solutions Drives Adoption
  • Expansion of Sports and Fitness Markets Accelerates Demand for Fast-Acting Topicals
  • Direct-to-Consumer Wellness Branding Strengthens Business Case for OTC Formulations
  • Rising Incidence of Diabetic Neuropathy and Arthritis Generates Demand
  • Innovations in Transdermal Drug Delivery Systems Expand Product Efficacy
  • Growth in Organic and Natural Ingredient Demand Spurs Clean-Label Topical Launches
  • Chronic Pain Management Guidelines Spotlight Topical Alternatives to Systemic Medications
  • Integration in Telehealth and E-Pharmacy Channels Accelerates Market Access
  • Customizable Formulations for Personalized Pain Relief Generate New Consumer Segments
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Topical Pain Relief Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Topical Pain Relief by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Topical Pain Relief by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Topical Pain Relief by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Opioids / Narcotics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Opioids / Narcotics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Opioids / Narcotics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Non-Opioids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Non-Opioids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Non-Opioids by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Online Platforms by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Online Platforms by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Online Platforms by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Other Distribution Channels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Other Distribution Channels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Other Distribution Channels by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Hospital Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Retail Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Drug Stores by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Drug Stores by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Drug Stores by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Sprays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Sprays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Sprays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Patches by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Patches by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Patches by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Creams by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Creams by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Creams by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Foams by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Foams by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Foams by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Topical Pain Relief Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 38: USA Recent Past, Current & Future Analysis for Topical Pain Relief by Class - Opioids / Narcotics and Non-Opioids - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 39: USA Historic Review for Topical Pain Relief by Class - Opioids / Narcotics and Non-Opioids Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: USA 15-Year Perspective for Topical Pain Relief by Class - Percentage Breakdown of Value Sales for Opioids / Narcotics and Non-Opioids for the Years 2015, 2025 & 2030
  • TABLE 41: USA Recent Past, Current & Future Analysis for Topical Pain Relief by Distributional Channel - Online Platforms, Other Distribution Channels, Hospital Pharmacies, Retail Pharmacies and Drug Stores - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 42: USA Historic Review for Topical Pain Relief by Distributional Channel - Online Platforms, Other Distribution Channels, Hospital Pharmacies, Retail Pharmacies and Drug Stores Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: USA 15-Year Perspective for Topical Pain Relief by Distributional Channel - Percentage Breakdown of Value Sales for Online Platforms, Other Distribution Channels, Hospital Pharmacies, Retail Pharmacies and Drug Stores for the Years 2015, 2025 & 2030
  • TABLE 44: USA Recent Past, Current & Future Analysis for Topical Pain Relief by Form - Sprays, Patches, Creams and Foams - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: USA Historic Review for Topical Pain Relief by Form - Sprays, Patches, Creams and Foams Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: USA 15-Year Perspective for Topical Pain Relief by Form - Percentage Breakdown of Value Sales for Sprays, Patches, Creams and Foams for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 47: Canada Recent Past, Current & Future Analysis for Topical Pain Relief by Class - Opioids / Narcotics and Non-Opioids - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Canada Historic Review for Topical Pain Relief by Class - Opioids / Narcotics and Non-Opioids Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: Canada 15-Year Perspective for Topical Pain Relief by Class - Percentage Breakdown of Value Sales for Opioids / Narcotics and Non-Opioids for the Years 2015, 2025 & 2030
  • TABLE 50: Canada Recent Past, Current & Future Analysis for Topical Pain Relief by Distributional Channel - Online Platforms, Other Distribution Channels, Hospital Pharmacies, Retail Pharmacies and Drug Stores - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Canada Historic Review for Topical Pain Relief by Distributional Channel - Online Platforms, Other Distribution Channels, Hospital Pharmacies, Retail Pharmacies and Drug Stores Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: Canada 15-Year Perspective for Topical Pain Relief by Distributional Channel - Percentage Breakdown of Value Sales for Online Platforms, Other Distribution Channels, Hospital Pharmacies, Retail Pharmacies and Drug Stores for the Years 2015, 2025 & 2030
  • TABLE 53: Canada Recent Past, Current & Future Analysis for Topical Pain Relief by Form - Sprays, Patches, Creams and Foams - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Canada Historic Review for Topical Pain Relief by Form - Sprays, Patches, Creams and Foams Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: Canada 15-Year Perspective for Topical Pain Relief by Form - Percentage Breakdown of Value Sales for Sprays, Patches, Creams and Foams for the Years 2015, 2025 & 2030
• JAPAN
  • Topical Pain Relief Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 56: Japan Recent Past, Current & Future Analysis for Topical Pain Relief by Class - Opioids / Narcotics and Non-Opioids - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Japan Historic Review for Topical Pain Relief by Class - Opioids / Narcotics and Non-Opioids Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: Japan 15-Year Perspective for Topical Pain Relief by Class - Percentage Breakdown of Value Sales for Opioids / Narcotics and Non-Opioids for the Years 2015, 2025 & 2030
  • TABLE 59: Japan Recent Past, Current & Future Analysis for Topical Pain Relief by Distributional Channel - Online Platforms, Other Distribution Channels, Hospital Pharmacies, Retail Pharmacies and Drug Stores - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Japan Historic Review for Topical Pain Relief by Distributional Channel - Online Platforms, Other Distribution Channels, Hospital Pharmacies, Retail Pharmacies and Drug Stores Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: Japan 15-Year Perspective for Topical Pain Relief by Distributional Channel - Percentage Breakdown of Value Sales for Online Platforms, Other Distribution Channels, Hospital Pharmacies, Retail Pharmacies and Drug Stores for the Years 2015, 2025 & 2030
  • TABLE 62: Japan Recent Past, Current & Future Analysis for Topical Pain Relief by Form - Sprays, Patches, Creams and Foams - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Japan Historic Review for Topical Pain Relief by Form - Sprays, Patches, Creams and Foams Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: Japan 15-Year Perspective for Topical Pain Relief by Form - Percentage Breakdown of Value Sales for Sprays, Patches, Creams and Foams for the Years 2015, 2025 & 2030
• CHINA
  • Topical Pain Relief Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 65: China Recent Past, Current & Future Analysis for Topical Pain Relief by Class - Opioids / Narcotics and Non-Opioids - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: China Historic Review for Topical Pain Relief by Class - Opioids / Narcotics and Non-Opioids Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: China 15-Year Perspective for Topical Pain Relief by Class - Percentage Breakdown of Value Sales for Opioids / Narcotics and Non-Opioids for the Years 2015, 2025 & 2030
  • TABLE 68: China Recent Past, Current & Future Analysis for Topical Pain Relief by Distributional Channel - Online Platforms, Other Distribution Channels, Hospital Pharmacies, Retail Pharmacies and Drug Stores - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: China Historic Review for Topical Pain Relief by Distributional Channel - Online Platforms, Other Distribution Channels, Hospital Pharmacies, Retail Pharmacies and Drug Stores Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: China 15-Year Perspective for Topical Pain Relief by Distributional Channel - Percentage Breakdown of Value Sales for Online Platforms, Other Distribution Channels, Hospital Pharmacies, Retail Pharmacies and Drug Stores for the Years 2015, 2025 & 2030
  • TABLE 71: China Recent Past, Current & Future Analysis for Topical Pain Relief by Form - Sprays, Patches, Creams and Foams - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: China Historic Review for Topical Pain Relief by Form - Sprays, Patches, Creams and Foams Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: China 15-Year Perspective for Topical Pain Relief by Form - Percentage Breakdown of Value Sales for Sprays, Patches, Creams and Foams for the Years 2015, 2025 & 2030
• EUROPE
  • Topical Pain Relief Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 74: Europe Recent Past, Current & Future Analysis for Topical Pain Relief by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 75: Europe Historic Review for Topical Pain Relief by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: Europe 15-Year Perspective for Topical Pain Relief by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 77: Europe Recent Past, Current & Future Analysis for Topical Pain Relief by Class - Opioids / Narcotics and Non-Opioids - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Europe Historic Review for Topical Pain Relief by Class - Opioids / Narcotics and Non-Opioids Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: Europe 15-Year Perspective for Topical Pain Relief by Class - Percentage Breakdown of Value Sales for Opioids / Narcotics and Non-Opioids for the Years 2015, 2025 & 2030
  • TABLE 80: Europe Recent Past, Current & Future Analysis for Topical Pain Relief by Distributional Channel - Online Platforms, Other Distribution Channels, Hospital Pharmacies, Retail Pharmacies and Drug Stores - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Europe Historic Review for Topical Pain Relief by Distributional Channel - Online Platforms, Other Distribution Channels, Hospital Pharmacies, Retail Pharmacies and Drug Stores Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: Europe 15-Year Perspective for Topical Pain Relief by Distributional Channel - Percentage Breakdown of Value Sales for Online Platforms, Other Distribution Channels, Hospital Pharmacies, Retail Pharmacies and Drug Stores for the Years 2015, 2025 & 2030
  • TABLE 83: Europe Recent Past, Current & Future Analysis for Topical Pain Relief by Form - Sprays, Patches, Creams and Foams - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Europe Historic Review for Topical Pain Relief by Form - Sprays, Patches, Creams and Foams Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: Europe 15-Year Perspective for Topical Pain Relief by Form - Percentage Breakdown of Value Sales for Sprays, Patches, Creams and Foams for the Years 2015, 2025 & 2030
• FRANCE
  • Topical Pain Relief Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 86: France Recent Past, Current & Future Analysis for Topical Pain Relief by Class - Opioids / Narcotics and Non-Opioids - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: France Historic Review for Topical Pain Relief by Class - Opioids / Narcotics and Non-Opioids Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: France 15-Year Perspective for Topical Pain Relief by Class - Percentage Breakdown of Value Sales for Opioids / Narcotics and Non-Opioids for the Years 2015, 2025 & 2030
  • TABLE 89: France Recent Past, Current & Future Analysis for Topical Pain Relief by Distributional Channel - Online Platforms, Other Distribution Channels, Hospital Pharmacies, Retail Pharmacies and Drug Stores - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: France Historic Review for Topical Pain Relief by Distributional Channel - Online Platforms, Other Distribution Channels, Hospital Pharmacies, Retail Pharmacies and Drug Stores Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: France 15-Year Perspective for Topical Pain Relief by Distributional Channel - Percentage Breakdown of Value Sales for Online Platforms, Other Distribution Channels, Hospital Pharmacies, Retail Pharmacies and Drug Stores for the Years 2015, 2025 & 2030
  • TABLE 92: France Recent Past, Current & Future Analysis for Topical Pain Relief by Form - Sprays, Patches, Creams and Foams - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: France Historic Review for Topical Pain Relief by Form - Sprays, Patches, Creams and Foams Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: France 15-Year Perspective for Topical Pain Relief by Form - Percentage Breakdown of Value Sales for Sprays, Patches, Creams and Foams for the Years 2015, 2025 & 2030
• GERMANY
  • Topical Pain Relief Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 95: Germany Recent Past, Current & Future Analysis for Topical Pain Relief by Class - Opioids / Narcotics and Non-Opioids - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Germany Historic Review for Topical Pain Relief by Class - Opioids / Narcotics and Non-Opioids Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: Germany 15-Year Perspective for Topical Pain Relief by Class - Percentage Breakdown of Value Sales for Opioids / Narcotics and Non-Opioids for the Years 2015, 2025 & 2030
  • TABLE 98: Germany Recent Past, Current & Future Analysis for Topical Pain Relief by Distributional Channel - Online Platforms, Other Distribution Channels, Hospital Pharmacies, Retail Pharmacies and Drug Stores - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Germany Historic Review for Topical Pain Relief by Distributional Channel - Online Platforms, Other Distribution Channels, Hospital Pharmacies, Retail Pharmacies and Drug Stores Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: Germany 15-Year Perspective for Topical Pain Relief by Distributional Channel - Percentage Breakdown of Value Sales for Online Platforms, Other Distribution Channels, Hospital Pharmacies, Retail Pharmacies and Drug Stores for the Years 2015, 2025 & 2030
  • TABLE 101: Germany Recent Past, Current & Future Analysis for Topical Pain Relief by Form - Sprays, Patches, Creams and Foams - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Germany Historic Review for Topical Pain Relief by Form - Sprays, Patches, Creams and Foams Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: Germany 15-Year Perspective for Topical Pain Relief by Form - Percentage Breakdown of Value Sales for Sprays, Patches, Creams and Foams for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 104: Italy Recent Past, Current & Future Analysis for Topical Pain Relief by Class - Opioids / Narcotics and Non-Opioids - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Italy Historic Review for Topical Pain Relief by Class - Opioids / Narcotics and Non-Opioids Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: Italy 15-Year Perspective for Topical Pain Relief by Class - Percentage Breakdown of Value Sales for Opioids / Narcotics and Non-Opioids for the Years 2015, 2025 & 2030
  • TABLE 107: Italy Recent Past, Current & Future Analysis for Topical Pain Relief by Distributional Channel - Online Platforms, Other Distribution Channels, Hospital Pharmacies, Retail Pharmacies and Drug Stores - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Italy Historic Review for Topical Pain Relief by Distributional Channel - Online Platforms, Other Distribution Channels, Hospital Pharmacies, Retail Pharmacies and Drug Stores Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: Italy 15-Year Perspective for Topical Pain Relief by Distributional Channel - Percentage Breakdown of Value Sales for Online Platforms, Other Distribution Channels, Hospital Pharmacies, Retail Pharmacies and Drug Stores for the Years 2015, 2025 & 2030
  • TABLE 110: Italy Recent Past, Current & Future Analysis for Topical Pain Relief by Form - Sprays, Patches, Creams and Foams - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Italy Historic Review for Topical Pain Relief by Form - Sprays, Patches, Creams and Foams Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: Italy 15-Year Perspective for Topical Pain Relief by Form - Percentage Breakdown of Value Sales for Sprays, Patches, Creams and Foams for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Topical Pain Relief Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 113: UK Recent Past, Current & Future Analysis for Topical Pain Relief by Class - Opioids / Narcotics and Non-Opioids - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: UK Historic Review for Topical Pain Relief by Class - Opioids / Narcotics and Non-Opioids Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: UK 15-Year Perspective for Topical Pain Relief by Class - Percentage Breakdown of Value Sales for Opioids / Narcotics and Non-Opioids for the Years 2015, 2025 & 2030
  • TABLE 116: UK Recent Past, Current & Future Analysis for Topical Pain Relief by Distributional Channel - Online Platforms, Other Distribution Channels, Hospital Pharmacies, Retail Pharmacies and Drug Stores - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: UK Historic Review for Topical Pain Relief by Distributional Channel - Online Platforms, Other Distribution Channels, Hospital Pharmacies, Retail Pharmacies and Drug Stores Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: UK 15-Year Perspective for Topical Pain Relief by Distributional Channel - Percentage Breakdown of Value Sales for Online Platforms, Other Distribution Channels, Hospital Pharmacies, Retail Pharmacies and Drug Stores for the Years 2015, 2025 & 2030
  • TABLE 119: UK Recent Past, Current & Future Analysis for Topical Pain Relief by Form - Sprays, Patches, Creams and Foams - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: UK Historic Review for Topical Pain Relief by Form - Sprays, Patches, Creams and Foams Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: UK 15-Year Perspective for Topical Pain Relief by Form - Percentage Breakdown of Value Sales for Sprays, Patches, Creams and Foams for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 122: Spain Recent Past, Current & Future Analysis for Topical Pain Relief by Class - Opioids / Narcotics and Non-Opioids - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Spain Historic Review for Topical Pain Relief by Class - Opioids / Narcotics and Non-Opioids Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: Spain 15-Year Perspective for Topical Pain Relief by Class - Percentage Breakdown of Value Sales for Opioids / Narcotics and Non-Opioids for the Years 2015, 2025 & 2030
  • TABLE 125: Spain Recent Past, Current & Future Analysis for Topical Pain Relief by Distributional Channel - Online Platforms, Other Distribution Channels, Hospital Pharmacies, Retail Pharmacies and Drug Stores - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Spain Historic Review for Topical Pain Relief by Distributional Channel - Online Platforms, Other Distribution Channels, Hospital Pharmacies, Retail Pharmacies and Drug Stores Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: Spain 15-Year Perspective for Topical Pain Relief by Distributional Channel - Percentage Breakdown of Value Sales for Online Platforms, Other Distribution Channels, Hospital Pharmacies, Retail Pharmacies and Drug Stores for the Years 2015, 2025 & 2030
  • TABLE 128: Spain Recent Past, Current & Future Analysis for Topical Pain Relief by Form - Sprays, Patches, Creams and Foams - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Spain Historic Review for Topical Pain Relief by Form - Sprays, Patches, Creams and Foams Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: Spain 15-Year Perspective for Topical Pain Relief by Form - Percentage Breakdown of Value Sales for Sprays, Patches, Creams and Foams for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 131: Russia Recent Past, Current & Future Analysis for Topical Pain Relief by Class - Opioids / Narcotics and Non-Opioids - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Russia Historic Review for Topical Pain Relief by Class - Opioids / Narcotics and Non-Opioids Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: Russia 15-Year Perspective for Topical Pain Relief by Class - Percentage Breakdown of Value Sales for Opioids / Narcotics and Non-Opioids for the Years 2015, 2025 & 2030
  • TABLE 134: Russia Recent Past, Current & Future Analysis for Topical Pain Relief by Distributional Channel - Online Platforms, Other Distribution Channels, Hospital Pharmacies, Retail Pharmacies and Drug Stores - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Russia Historic Review for Topical Pain Relief by Distributional Channel - Online Platforms, Other Distribution Channels, Hospital Pharmacies, Retail Pharmacies and Drug Stores Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: Russia 15-Year Perspective for Topical Pain Relief by Distributional Channel - Percentage Breakdown of Value Sales for Online Platforms, Other Distribution Channels, Hospital Pharmacies, Retail Pharmacies and Drug Stores for the Years 2015, 2025 & 2030
  • TABLE 137: Russia Recent Past, Current & Future Analysis for Topical Pain Relief by Form - Sprays, Patches, Creams and Foams - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Russia Historic Review for Topical Pain Relief by Form - Sprays, Patches, Creams and Foams Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: Russia 15-Year Perspective for Topical Pain Relief by Form - Percentage Breakdown of Value Sales for Sprays, Patches, Creams and Foams for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Topical Pain Relief by Class - Opioids / Narcotics and Non-Opioids - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Rest of Europe Historic Review for Topical Pain Relief by Class - Opioids / Narcotics and Non-Opioids Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: Rest of Europe 15-Year Perspective for Topical Pain Relief by Class - Percentage Breakdown of Value Sales for Opioids / Narcotics and Non-Opioids for the Years 2015, 2025 & 2030
  • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Topical Pain Relief by Distributional Channel - Online Platforms, Other Distribution Channels, Hospital Pharmacies, Retail Pharmacies and Drug Stores - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Rest of Europe Historic Review for Topical Pain Relief by Distributional Channel - Online Platforms, Other Distribution Channels, Hospital Pharmacies, Retail Pharmacies and Drug Stores Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: Rest of Europe 15-Year Perspective for Topical Pain Relief by Distributional Channel - Percentage Breakdown of Value Sales for Online Platforms, Other Distribution Channels, Hospital Pharmacies, Retail Pharmacies and Drug Stores for the Years 2015, 2025 & 2030
  • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Topical Pain Relief by Form - Sprays, Patches, Creams and Foams - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Rest of Europe Historic Review for Topical Pain Relief by Form - Sprays, Patches, Creams and Foams Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: Rest of Europe 15-Year Perspective for Topical Pain Relief by Form - Percentage Breakdown of Value Sales for Sprays, Patches, Creams and Foams for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Topical Pain Relief Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Topical Pain Relief by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 150: Asia-Pacific Historic Review for Topical Pain Relief by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: Asia-Pacific 15-Year Perspective for Topical Pain Relief by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Topical Pain Relief by Class - Opioids / Narcotics and Non-Opioids - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Asia-Pacific Historic Review for Topical Pain Relief by Class - Opioids / Narcotics and Non-Opioids Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: Asia-Pacific 15-Year Perspective for Topical Pain Relief by Class - Percentage Breakdown of Value Sales for Opioids / Narcotics and Non-Opioids for the Years 2015, 2025 & 2030
  • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Topical Pain Relief by Distributional Channel - Online Platforms, Other Distribution Channels, Hospital Pharmacies, Retail Pharmacies and Drug Stores - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Asia-Pacific Historic Review for Topical Pain Relief by Distributional Channel - Online Platforms, Other Distribution Channels, Hospital Pharmacies, Retail Pharmacies and Drug Stores Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: Asia-Pacific 15-Year Perspective for Topical Pain Relief by Distributional Channel - Percentage Breakdown of Value Sales for Online Platforms, Other Distribution Channels, Hospital Pharmacies, Retail Pharmacies and Drug Stores for the Years 2015, 2025 & 2030
  • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Topical Pain Relief by Form - Sprays, Patches, Creams and Foams - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Asia-Pacific Historic Review for Topical Pain Relief by Form - Sprays, Patches, Creams and Foams Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: Asia-Pacific 15-Year Perspective for Topical Pain Relief by Form - Percentage Breakdown of Value Sales for Sprays, Patches, Creams and Foams for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Topical Pain Relief Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 161: Australia Recent Past, Current & Future Analysis for Topical Pain Relief by Class - Opioids / Narcotics and Non-Opioids - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Australia Historic Review for Topical Pain Relief by Class - Opioids / Narcotics and Non-Opioids Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: Australia 15-Year Perspective for Topical Pain Relief by Class - Percentage Breakdown of Value Sales for Opioids / Narcotics and Non-Opioids for the Years 2015, 2025 & 2030
  • TABLE 164: Australia Recent Past, Current & Future Analysis for Topical Pain Relief by Distributional Channel - Online Platforms, Other Distribution Channels, Hospital Pharmacies, Retail Pharmacies and Drug Stores - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Australia Historic Review for Topical Pain Relief by Distributional Channel - Online Platforms, Other Distribution Channels, Hospital Pharmacies, Retail Pharmacies and Drug Stores Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: Australia 15-Year Perspective for Topical Pain Relief by Distributional Channel - Percentage Breakdown of Value Sales for Online Platforms, Other Distribution Channels, Hospital Pharmacies, Retail Pharmacies and Drug Stores for the Years 2015, 2025 & 2030
  • TABLE 167: Australia Recent Past, Current & Future Analysis for Topical Pain Relief by Form - Sprays, Patches, Creams and Foams - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Australia Historic Review for Topical Pain Relief by Form - Sprays, Patches, Creams and Foams Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: Australia 15-Year Perspective for Topical Pain Relief by Form - Percentage Breakdown of Value Sales for Sprays, Patches, Creams and Foams for the Years 2015, 2025 & 2030
• INDIA
  • Topical Pain Relief Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 170: India Recent Past, Current & Future Analysis for Topical Pain Relief by Class - Opioids / Narcotics and Non-Opioids - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: India Historic Review for Topical Pain Relief by Class - Opioids / Narcotics and Non-Opioids Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: India 15-Year Perspective for Topical Pain Relief by Class - Percentage Breakdown of Value Sales for Opioids / Narcotics and Non-Opioids for the Years 2015, 2025 & 2030
  • TABLE 173: India Recent Past, Current & Future Analysis for Topical Pain Relief by Distributional Channel - Online Platforms, Other Distribution Channels, Hospital Pharmacies, Retail Pharmacies and Drug Stores - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: India Historic Review for Topical Pain Relief by Distributional Channel - Online Platforms, Other Distribution Channels, Hospital Pharmacies, Retail Pharmacies and Drug Stores Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: India 15-Year Perspective for Topical Pain Relief by Distributional Channel - Percentage Breakdown of Value Sales for Online Platforms, Other Distribution Channels, Hospital Pharmacies, Retail Pharmacies and Drug Stores for the Years 2015, 2025 & 2030
  • TABLE 176: India Recent Past, Current & Future Analysis for Topical Pain Relief by Form - Sprays, Patches, Creams and Foams - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: India Historic Review for Topical Pain Relief by Form - Sprays, Patches, Creams and Foams Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: India 15-Year Perspective for Topical Pain Relief by Form - Percentage Breakdown of Value Sales for Sprays, Patches, Creams and Foams for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 179: South Korea Recent Past, Current & Future Analysis for Topical Pain Relief by Class - Opioids / Narcotics and Non-Opioids - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: South Korea Historic Review for Topical Pain Relief by Class - Opioids / Narcotics and Non-Opioids Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: South Korea 15-Year Perspective for Topical Pain Relief by Class - Percentage Breakdown of Value Sales for Opioids / Narcotics and Non-Opioids for the Years 2015, 2025 & 2030
  • TABLE 182: South Korea Recent Past, Current & Future Analysis for Topical Pain Relief by Distributional Channel - Online Platforms, Other Distribution Channels, Hospital Pharmacies, Retail Pharmacies and Drug Stores - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: South Korea Historic Review for Topical Pain Relief by Distributional Channel - Online Platforms, Other Distribution Channels, Hospital Pharmacies, Retail Pharmacies and Drug Stores Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: South Korea 15-Year Perspective for Topical Pain Relief by Distributional Channel - Percentage Breakdown of Value Sales for Online Platforms, Other Distribution Channels, Hospital Pharmacies, Retail Pharmacies and Drug Stores for the Years 2015, 2025 & 2030
  • TABLE 185: South Korea Recent Past, Current & Future Analysis for Topical Pain Relief by Form - Sprays, Patches, Creams and Foams - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: South Korea Historic Review for Topical Pain Relief by Form - Sprays, Patches, Creams and Foams Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: South Korea 15-Year Perspective for Topical Pain Relief by Form - Percentage Breakdown of Value Sales for Sprays, Patches, Creams and Foams for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Topical Pain Relief by Class - Opioids / Narcotics and Non-Opioids - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Rest of Asia-Pacific Historic Review for Topical Pain Relief by Class - Opioids / Narcotics and Non-Opioids Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Topical Pain Relief by Class - Percentage Breakdown of Value Sales for Opioids / Narcotics and Non-Opioids for the Years 2015, 2025 & 2030
  • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Topical Pain Relief by Distributional Channel - Online Platforms, Other Distribution Channels, Hospital Pharmacies, Retail Pharmacies and Drug Stores - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Rest of Asia-Pacific Historic Review for Topical Pain Relief by Distributional Channel - Online Platforms, Other Distribution Channels, Hospital Pharmacies, Retail Pharmacies and Drug Stores Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Topical Pain Relief by Distributional Channel - Percentage Breakdown of Value Sales for Online Platforms, Other Distribution Channels, Hospital Pharmacies, Retail Pharmacies and Drug Stores for the Years 2015, 2025 & 2030
  • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Topical Pain Relief by Form - Sprays, Patches, Creams and Foams - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Rest of Asia-Pacific Historic Review for Topical Pain Relief by Form - Sprays, Patches, Creams and Foams Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: Rest of Asia-Pacific 15-Year Perspective for Topical Pain Relief by Form - Percentage Breakdown of Value Sales for Sprays, Patches, Creams and Foams for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Topical Pain Relief Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 197: Latin America Recent Past, Current & Future Analysis for Topical Pain Relief by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 198: Latin America Historic Review for Topical Pain Relief by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: Latin America 15-Year Perspective for Topical Pain Relief by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 200: Latin America Recent Past, Current & Future Analysis for Topical Pain Relief by Class - Opioids / Narcotics and Non-Opioids - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Latin America Historic Review for Topical Pain Relief by Class - Opioids / Narcotics and Non-Opioids Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: Latin America 15-Year Perspective for Topical Pain Relief by Class - Percentage Breakdown of Value Sales for Opioids / Narcotics and Non-Opioids for the Years 2015, 2025 & 2030
  • TABLE 203: Latin America Recent Past, Current & Future Analysis for Topical Pain Relief by Distributional Channel - Online Platforms, Other Distribution Channels, Hospital Pharmacies, Retail Pharmacies and Drug Stores - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Latin America Historic Review for Topical Pain Relief by Distributional Channel - Online Platforms, Other Distribution Channels, Hospital Pharmacies, Retail Pharmacies and Drug Stores Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Latin America 15-Year Perspective for Topical Pain Relief by Distributional Channel - Percentage Breakdown of Value Sales for Online Platforms, Other Distribution Channels, Hospital Pharmacies, Retail Pharmacies and Drug Stores for the Years 2015, 2025 & 2030
  • TABLE 206: Latin America Recent Past, Current & Future Analysis for Topical Pain Relief by Form - Sprays, Patches, Creams and Foams - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Latin America Historic Review for Topical Pain Relief by Form - Sprays, Patches, Creams and Foams Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Latin America 15-Year Perspective for Topical Pain Relief by Form - Percentage Breakdown of Value Sales for Sprays, Patches, Creams and Foams for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 209: Argentina Recent Past, Current & Future Analysis for Topical Pain Relief by Class - Opioids / Narcotics and Non-Opioids - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Argentina Historic Review for Topical Pain Relief by Class - Opioids / Narcotics and Non-Opioids Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: Argentina 15-Year Perspective for Topical Pain Relief by Class - Percentage Breakdown of Value Sales for Opioids / Narcotics and Non-Opioids for the Years 2015, 2025 & 2030
  • TABLE 212: Argentina Recent Past, Current & Future Analysis for Topical Pain Relief by Distributional Channel - Online Platforms, Other Distribution Channels, Hospital Pharmacies, Retail Pharmacies and Drug Stores - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Argentina Historic Review for Topical Pain Relief by Distributional Channel - Online Platforms, Other Distribution Channels, Hospital Pharmacies, Retail Pharmacies and Drug Stores Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: Argentina 15-Year Perspective for Topical Pain Relief by Distributional Channel - Percentage Breakdown of Value Sales for Online Platforms, Other Distribution Channels, Hospital Pharmacies, Retail Pharmacies and Drug Stores for the Years 2015, 2025 & 2030
  • TABLE 215: Argentina Recent Past, Current & Future Analysis for Topical Pain Relief by Form - Sprays, Patches, Creams and Foams - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Argentina Historic Review for Topical Pain Relief by Form - Sprays, Patches, Creams and Foams Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: Argentina 15-Year Perspective for Topical Pain Relief by Form - Percentage Breakdown of Value Sales for Sprays, Patches, Creams and Foams for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 218: Brazil Recent Past, Current & Future Analysis for Topical Pain Relief by Class - Opioids / Narcotics and Non-Opioids - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Brazil Historic Review for Topical Pain Relief by Class - Opioids / Narcotics and Non-Opioids Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: Brazil 15-Year Perspective for Topical Pain Relief by Class - Percentage Breakdown of Value Sales for Opioids / Narcotics and Non-Opioids for the Years 2015, 2025 & 2030
  • TABLE 221: Brazil Recent Past, Current & Future Analysis for Topical Pain Relief by Distributional Channel - Online Platforms, Other Distribution Channels, Hospital Pharmacies, Retail Pharmacies and Drug Stores - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Brazil Historic Review for Topical Pain Relief by Distributional Channel - Online Platforms, Other Distribution Channels, Hospital Pharmacies, Retail Pharmacies and Drug Stores Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: Brazil 15-Year Perspective for Topical Pain Relief by Distributional Channel - Percentage Breakdown of Value Sales for Online Platforms, Other Distribution Channels, Hospital Pharmacies, Retail Pharmacies and Drug Stores for the Years 2015, 2025 & 2030
  • TABLE 224: Brazil Recent Past, Current & Future Analysis for Topical Pain Relief by Form - Sprays, Patches, Creams and Foams - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Brazil Historic Review for Topical Pain Relief by Form - Sprays, Patches, Creams and Foams Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: Brazil 15-Year Perspective for Topical Pain Relief by Form - Percentage Breakdown of Value Sales for Sprays, Patches, Creams and Foams for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 227: Mexico Recent Past, Current & Future Analysis for Topical Pain Relief by Class - Opioids / Narcotics and Non-Opioids - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Mexico Historic Review for Topical Pain Relief by Class - Opioids / Narcotics and Non-Opioids Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: Mexico 15-Year Perspective for Topical Pain Relief by Class - Percentage Breakdown of Value Sales for Opioids / Narcotics and Non-Opioids for the Years 2015, 2025 & 2030
  • TABLE 230: Mexico Recent Past, Current & Future Analysis for Topical Pain Relief by Distributional Channel - Online Platforms, Other Distribution Channels, Hospital Pharmacies, Retail Pharmacies and Drug Stores - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Mexico Historic Review for Topical Pain Relief by Distributional Channel - Online Platforms, Other Distribution Channels, Hospital Pharmacies, Retail Pharmacies and Drug Stores Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 232: Mexico 15-Year Perspective for Topical Pain Relief by Distributional Channel - Percentage Breakdown of Value Sales for Online Platforms, Other Distribution Channels, Hospital Pharmacies, Retail Pharmacies and Drug Stores for the Years 2015, 2025 & 2030
  • TABLE 233: Mexico Recent Past, Current & Future Analysis for Topical Pain Relief by Form - Sprays, Patches, Creams and Foams - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Mexico Historic Review for Topical Pain Relief by Form - Sprays, Patches, Creams and Foams Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 235: Mexico 15-Year Perspective for Topical Pain Relief by Form - Percentage Breakdown of Value Sales for Sprays, Patches, Creams and Foams for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Topical Pain Relief by Class - Opioids / Narcotics and Non-Opioids - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Rest of Latin America Historic Review for Topical Pain Relief by Class - Opioids / Narcotics and Non-Opioids Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 238: Rest of Latin America 15-Year Perspective for Topical Pain Relief by Class - Percentage Breakdown of Value Sales for Opioids / Narcotics and Non-Opioids for the Years 2015, 2025 & 2030
  • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Topical Pain Relief by Distributional Channel - Online Platforms, Other Distribution Channels, Hospital Pharmacies, Retail Pharmacies and Drug Stores - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Rest of Latin America Historic Review for Topical Pain Relief by Distributional Channel - Online Platforms, Other Distribution Channels, Hospital Pharmacies, Retail Pharmacies and Drug Stores Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 241: Rest of Latin America 15-Year Perspective for Topical Pain Relief by Distributional Channel - Percentage Breakdown of Value Sales for Online Platforms, Other Distribution Channels, Hospital Pharmacies, Retail Pharmacies and Drug Stores for the Years 2015, 2025 & 2030
  • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Topical Pain Relief by Form - Sprays, Patches, Creams and Foams - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Rest of Latin America Historic Review for Topical Pain Relief by Form - Sprays, Patches, Creams and Foams Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 244: Rest of Latin America 15-Year Perspective for Topical Pain Relief by Form - Percentage Breakdown of Value Sales for Sprays, Patches, Creams and Foams for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Topical Pain Relief Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 245: Middle East Recent Past, Current & Future Analysis for Topical Pain Relief by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 246: Middle East Historic Review for Topical Pain Relief by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 247: Middle East 15-Year Perspective for Topical Pain Relief by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 248: Middle East Recent Past, Current & Future Analysis for Topical Pain Relief by Class - Opioids / Narcotics and Non-Opioids - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Middle East Historic Review for Topical Pain Relief by Class - Opioids / Narcotics and Non-Opioids Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 250: Middle East 15-Year Perspective for Topical Pain Relief by Class - Percentage Breakdown of Value Sales for Opioids / Narcotics and Non-Opioids for the Years 2015, 2025 & 2030
  • TABLE 251: Middle East Recent Past, Current & Future Analysis for Topical Pain Relief by Distributional Channel - Online Platforms, Other Distribution Channels, Hospital Pharmacies, Retail Pharmacies and Drug Stores - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Middle East Historic Review for Topical Pain Relief by Distributional Channel - Online Platforms, Other Distribution Channels, Hospital Pharmacies, Retail Pharmacies and Drug Stores Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 253: Middle East 15-Year Perspective for Topical Pain Relief by Distributional Channel - Percentage Breakdown of Value Sales for Online Platforms, Other Distribution Channels, Hospital Pharmacies, Retail Pharmacies and Drug Stores for the Years 2015, 2025 & 2030
  • TABLE 254: Middle East Recent Past, Current & Future Analysis for Topical Pain Relief by Form - Sprays, Patches, Creams and Foams - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Middle East Historic Review for Topical Pain Relief by Form - Sprays, Patches, Creams and Foams Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 256: Middle East 15-Year Perspective for Topical Pain Relief by Form - Percentage Breakdown of Value Sales for Sprays, Patches, Creams and Foams for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 257: Iran Recent Past, Current & Future Analysis for Topical Pain Relief by Class - Opioids / Narcotics and Non-Opioids - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Iran Historic Review for Topical Pain Relief by Class - Opioids / Narcotics and Non-Opioids Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 259: Iran 15-Year Perspective for Topical Pain Relief by Class - Percentage Breakdown of Value Sales for Opioids / Narcotics and Non-Opioids for the Years 2015, 2025 & 2030
  • TABLE 260: Iran Recent Past, Current & Future Analysis for Topical Pain Relief by Distributional Channel - Online Platforms, Other Distribution Channels, Hospital Pharmacies, Retail Pharmacies and Drug Stores - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Iran Historic Review for Topical Pain Relief by Distributional Channel - Online Platforms, Other Distribution Channels, Hospital Pharmacies, Retail Pharmacies and Drug Stores Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 262: Iran 15-Year Perspective for Topical Pain Relief by Distributional Channel - Percentage Breakdown of Value Sales for Online Platforms, Other Distribution Channels, Hospital Pharmacies, Retail Pharmacies and Drug Stores for the Years 2015, 2025 & 2030
  • TABLE 263: Iran Recent Past, Current & Future Analysis for Topical Pain Relief by Form - Sprays, Patches, Creams and Foams - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Iran Historic Review for Topical Pain Relief by Form - Sprays, Patches, Creams and Foams Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 265: Iran 15-Year Perspective for Topical Pain Relief by Form - Percentage Breakdown of Value Sales for Sprays, Patches, Creams and Foams for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 266: Israel Recent Past, Current & Future Analysis for Topical Pain Relief by Class - Opioids / Narcotics and Non-Opioids - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Israel Historic Review for Topical Pain Relief by Class - Opioids / Narcotics and Non-Opioids Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 268: Israel 15-Year Perspective for Topical Pain Relief by Class - Percentage Breakdown of Value Sales for Opioids / Narcotics and Non-Opioids for the Years 2015, 2025 & 2030
  • TABLE 269: Israel Recent Past, Current & Future Analysis for Topical Pain Relief by Distributional Channel - Online Platforms, Other Distribution Channels, Hospital Pharmacies, Retail Pharmacies and Drug Stores - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Israel Historic Review for Topical Pain Relief by Distributional Channel - Online Platforms, Other Distribution Channels, Hospital Pharmacies, Retail Pharmacies and Drug Stores Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 271: Israel 15-Year Perspective for Topical Pain Relief by Distributional Channel - Percentage Breakdown of Value Sales for Online Platforms, Other Distribution Channels, Hospital Pharmacies, Retail Pharmacies and Drug Stores for the Years 2015, 2025 & 2030
  • TABLE 272: Israel Recent Past, Current & Future Analysis for Topical Pain Relief by Form - Sprays, Patches, Creams and Foams - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Israel Historic Review for Topical Pain Relief by Form - Sprays, Patches, Creams and Foams Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 274: Israel 15-Year Perspective for Topical Pain Relief by Form - Percentage Breakdown of Value Sales for Sprays, Patches, Creams and Foams for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Topical Pain Relief by Class - Opioids / Narcotics and Non-Opioids - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Saudi Arabia Historic Review for Topical Pain Relief by Class - Opioids / Narcotics and Non-Opioids Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 277: Saudi Arabia 15-Year Perspective for Topical Pain Relief by Class - Percentage Breakdown of Value Sales for Opioids / Narcotics and Non-Opioids for the Years 2015, 2025 & 2030
  • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Topical Pain Relief by Distributional Channel - Online Platforms, Other Distribution Channels, Hospital Pharmacies, Retail Pharmacies and Drug Stores - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Saudi Arabia Historic Review for Topical Pain Relief by Distributional Channel - Online Platforms, Other Distribution Channels, Hospital Pharmacies, Retail Pharmacies and Drug Stores Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 280: Saudi Arabia 15-Year Perspective for Topical Pain Relief by Distributional Channel - Percentage Breakdown of Value Sales for Online Platforms, Other Distribution Channels, Hospital Pharmacies, Retail Pharmacies and Drug Stores for the Years 2015, 2025 & 2030
  • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Topical Pain Relief by Form - Sprays, Patches, Creams and Foams - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Saudi Arabia Historic Review for Topical Pain Relief by Form - Sprays, Patches, Creams and Foams Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 283: Saudi Arabia 15-Year Perspective for Topical Pain Relief by Form - Percentage Breakdown of Value Sales for Sprays, Patches, Creams and Foams for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 284: UAE Recent Past, Current & Future Analysis for Topical Pain Relief by Class - Opioids / Narcotics and Non-Opioids - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: UAE Historic Review for Topical Pain Relief by Class - Opioids / Narcotics and Non-Opioids Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 286: UAE 15-Year Perspective for Topical Pain Relief by Class - Percentage Breakdown of Value Sales for Opioids / Narcotics and Non-Opioids for the Years 2015, 2025 & 2030
  • TABLE 287: UAE Recent Past, Current & Future Analysis for Topical Pain Relief by Distributional Channel - Online Platforms, Other Distribution Channels, Hospital Pharmacies, Retail Pharmacies and Drug Stores - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: UAE Historic Review for Topical Pain Relief by Distributional Channel - Online Platforms, Other Distribution Channels, Hospital Pharmacies, Retail Pharmacies and Drug Stores Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 289: UAE 15-Year Perspective for Topical Pain Relief by Distributional Channel - Percentage Breakdown of Value Sales for Online Platforms, Other Distribution Channels, Hospital Pharmacies, Retail Pharmacies and Drug Stores for the Years 2015, 2025 & 2030
  • TABLE 290: UAE Recent Past, Current & Future Analysis for Topical Pain Relief by Form - Sprays, Patches, Creams and Foams - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: UAE Historic Review for Topical Pain Relief by Form - Sprays, Patches, Creams and Foams Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 292: UAE 15-Year Perspective for Topical Pain Relief by Form - Percentage Breakdown of Value Sales for Sprays, Patches, Creams and Foams for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Topical Pain Relief by Class - Opioids / Narcotics and Non-Opioids - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Rest of Middle East Historic Review for Topical Pain Relief by Class - Opioids / Narcotics and Non-Opioids Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 295: Rest of Middle East 15-Year Perspective for Topical Pain Relief by Class - Percentage Breakdown of Value Sales for Opioids / Narcotics and Non-Opioids for the Years 2015, 2025 & 2030
  • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Topical Pain Relief by Distributional Channel - Online Platforms, Other Distribution Channels, Hospital Pharmacies, Retail Pharmacies and Drug Stores - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Rest of Middle East Historic Review for Topical Pain Relief by Distributional Channel - Online Platforms, Other Distribution Channels, Hospital Pharmacies, Retail Pharmacies and Drug Stores Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 298: Rest of Middle East 15-Year Perspective for Topical Pain Relief by Distributional Channel - Percentage Breakdown of Value Sales for Online Platforms, Other Distribution Channels, Hospital Pharmacies, Retail Pharmacies and Drug Stores for the Years 2015, 2025 & 2030
  • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Topical Pain Relief by Form - Sprays, Patches, Creams and Foams - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Rest of Middle East Historic Review for Topical Pain Relief by Form - Sprays, Patches, Creams and Foams Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 301: Rest of Middle East 15-Year Perspective for Topical Pain Relief by Form - Percentage Breakdown of Value Sales for Sprays, Patches, Creams and Foams for the Years 2015, 2025 & 2030
• AFRICA
  • Topical Pain Relief Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 302: Africa Recent Past, Current & Future Analysis for Topical Pain Relief by Class - Opioids / Narcotics and Non-Opioids - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Africa Historic Review for Topical Pain Relief by Class - Opioids / Narcotics and Non-Opioids Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 304: Africa 15-Year Perspective for Topical Pain Relief by Class - Percentage Breakdown of Value Sales for Opioids / Narcotics and Non-Opioids for the Years 2015, 2025 & 2030
  • TABLE 305: Africa Recent Past, Current & Future Analysis for Topical Pain Relief by Distributional Channel - Online Platforms, Other Distribution Channels, Hospital Pharmacies, Retail Pharmacies and Drug Stores - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Africa Historic Review for Topical Pain Relief by Distributional Channel - Online Platforms, Other Distribution Channels, Hospital Pharmacies, Retail Pharmacies and Drug Stores Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 307: Africa 15-Year Perspective for Topical Pain Relief by Distributional Channel - Percentage Breakdown of Value Sales for Online Platforms, Other Distribution Channels, Hospital Pharmacies, Retail Pharmacies and Drug Stores for the Years 2015, 2025 & 2030
  • TABLE 308: Africa Recent Past, Current & Future Analysis for Topical Pain Relief by Form - Sprays, Patches, Creams and Foams - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Africa Historic Review for Topical Pain Relief by Form - Sprays, Patches, Creams and Foams Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 310: Africa 15-Year Perspective for Topical Pain Relief by Form - Percentage Breakdown of Value Sales for Sprays, Patches, Creams and Foams for the Years 2015, 2025 & 2030

IV. COMPETITION